Filing Details

Accession Number:
0001209191-21-018935
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-09 16:04:49
Reporting Period:
2021-03-08
Accepted Time:
2021-03-09 16:04:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1549595 Nurix Therapeutics Inc. NRIX Pharmaceutical Preparations (2834) 270838048
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817226 Pierre Beaurang C/O Nurix Therapeutics, Inc.
1700 Owens Street, Suite 205
San Francisco CA 94158
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-08 7,500 $0.84 7,500 No 4 M Direct
Common Stock Disposition 2021-03-08 2,810 $36.48 4,690 No 4 S Direct
Common Stock Disposition 2021-03-08 4,490 $37.31 200 No 4 S Direct
Common Stock Disposition 2021-03-08 200 $38.34 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2021-03-08 7,500 $0.00 7,500 $0.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,726 2026-01-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 116,666 Indirect By Trust
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. Represents the weighted average sale price. The lowest price at which shares were sold was $35.93 and the highest price at which shares were sold was $36.91. The reporting person undertakes to provide upon request to the staff of the Securities Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
  3. Represents the weighted average sale price. The lowest price at which shares were sold was $36.94 and the highest price at which shares were sold was $37.63.
  4. Represents the weighted average sale price. The lowest price at which shares were sold was $38.23 and the highest price at which shares were sold was $38.45.
  5. The Reporting Person is a trustee of the Beaurang-Sligh Family Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
  6. The option is fully vested.